Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Last 14 days
Automated Applanation Tonometry - Updated
Group Acupuncture for Improved Pain Relief in Rural Communities
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity
Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer: A Pilot Study
Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)
Developing Pregnancy-specific Dialectical Behavior Therapy Skills to Promote Multigenerational Mental Health
The Impact of Music Intervention on Sleep: CoMPoSER Trial
RAndomized Cluster Evaluation of Cardiac ARrest Systems
Community and Physician Perceptions of Barriers to Care for Acute Coronary Syndrome Among HIV-infected and -Uninfected Patients in Moshi, Tanzania_1
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
ipratroprium — IPRATROPIUM BROMIDE
Application ANDA076025
ipratroprium — IPRATROPIUM BROMIDE
Application ANDA076025
ipratroprium — IPRATROPIUM BROMIDE
Application ANDA076025
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)